Literature DB >> 22262852

Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.

Kirsty M Brodie1, Beric R Henderson.   

Abstract

BRCA1 is a DNA damage response protein and functions in the nucleus to stimulate DNA repair and at the centrosome to inhibit centrosome overduplication in response to DNA damage. The loss or mutation of BRCA1 causes centrosome amplification and abnormal mitotic spindle assembly in breast cancer cells. The BRCA1-BARD1 heterodimer binds and ubiquitinates γ-tubulin to inhibit centrosome amplification and promote microtubule nucleation; however regulation of BRCA1 targeting and function at the centrosome is poorly understood. Here we show that both N and C termini of BRCA1 are required for its centrosomal localization and that BRCA1 moves to the centrosome independently of BARD1 and γ-tubulin. Mutations in the C-terminal phosphoprotein-binding BRCT domain of BRCA1 prevented localization to centrosomes. Photobleaching experiments identified dynamic (60%) and immobilized (40%) pools of ectopic BRCA1 at the centrosome, and these are regulated by the nuclear export receptor CRM1 (chromosome region maintenance 1) and BARD1. CRM1 mediates nuclear export of BRCA1, and mutation of the export sequence blocked BRCA1 regulation of centrosome amplification in irradiated cells. CRM1 binds to undimerized BRCA1 and is displaced by BARD1. Photobleaching assays implicate CRM1 in driving undimerized BRCA1 to the centrosome and revealed that when BRCA1 subsequently binds to BARD1, it is less well retained at centrosomes, suggesting a mechanism to accelerate BRCA1 release after formation of the active heterodimer. Moreover, Aurora A binding and phosphorylation of BRCA1 enhanced its centrosomal retention and regulation of centrosome amplification. Thus, CRM1, BARD1 and Aurora A promote the targeting and function of BRCA1 at centrosomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262852      PMCID: PMC3293534          DOI: 10.1074/jbc.M111.327296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.

Authors:  Reena Shakya; Latarsha J Reid; Colleen R Reczek; Francesca Cole; Dieter Egli; Chyuan-Sheng Lin; Dirk G deRooij; Steffen Hirsch; Kandasamy Ravi; James B Hicks; Matthias Szabolcs; Maria Jasin; Richard Baer; Thomas Ludwig
Journal:  Science       Date:  2011-10-28       Impact factor: 47.728

2.  Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.

Authors:  Kirsty M Brodie; Myth T S Mok; Beric R Henderson
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

Review 3.  Assembly and function of DNA double-strand break repair foci in mammalian cells.

Authors:  Simon Bekker-Jensen; Niels Mailand
Journal:  DNA Repair (Amst)       Date:  2010-10-28

4.  Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.

Authors:  Satish Sankaran; Lea M Starita; Amanda M Simons; Jeffrey D Parvin
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

Review 5.  BRCA1 phosphorylation: biological consequences.

Authors:  Toru Ouchi
Journal:  Cancer Biol Ther       Date:  2006-05-30       Impact factor: 4.742

6.  Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division.

Authors:  Akira Nakanishi; Xiangzi Han; Hiroko Saito; Keiko Taguchi; Yoshiyasu Ohta; Shinobu Imajoh-Ohmi; Yoshio Miki
Journal:  Biochem Biophys Res Commun       Date:  2007-01-26       Impact factor: 3.575

7.  Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.

Authors:  Kazuya Shinmura; Pheruza Tarapore; Yukari Tokuyama; Kyle R George; Kenji Fukasawa
Journal:  FEBS Lett       Date:  2005-11-09       Impact factor: 4.124

8.  Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells.

Authors:  Brian P Schlegel; Lea M Starita; Jeffrey D Parvin
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

9.  Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.

Authors:  Wendy W Y Au; Beric R Henderson
Journal:  Cell Signal       Date:  2007-05-01       Impact factor: 4.315

Review 10.  Cancer risks among BRCA1 and BRCA2 mutation carriers.

Authors:  E Levy-Lahad; E Friedman
Journal:  Br J Cancer       Date:  2007-01-15       Impact factor: 7.640

View more
  29 in total

1.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Phenethyl isothiocyanate suppresses the metastasis of ovarian cancer associated with the inhibition of CRM1-mediated nuclear export and mTOR-STAT3 pathway.

Authors:  Wen Yu Shao; Yong Liang Yang; Huan Yan; Qian Huang; Kai Jiang Liu; Shu Zhang
Journal:  Cancer Biol Ther       Date:  2016-12-16       Impact factor: 4.742

3.  The GTPase RAN regulates multiple steps of the centrosome life cycle.

Authors:  Patrizia Lavia
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

Review 4.  Nuclear transport factors: global regulation of mitosis.

Authors:  Douglass J Forbes; Anna Travesa; Matthew S Nord; Cyril Bernis
Journal:  Curr Opin Cell Biol       Date:  2015-05-15       Impact factor: 8.382

5.  BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.

Authors:  Jianqiu Zou; Deli Zhang; Guang Qin; Xiangming Chen; Hongmin Wang; Dong Zhang
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.

Authors:  Y-T Tai; Y Landesman; C Acharya; Y Calle; M Y Zhong; M Cea; D Tannenbaum; A Cagnetta; M Reagan; A A Munshi; W Senapedis; J R Saint-Martin; T Kashyap; S Shacham; M Kauffman; Y Gu; L Wu; I Ghobrial; F Zhan; A L Kung; S A Schey; P Richardson; N C Munshi; K C Anderson
Journal:  Leukemia       Date:  2013-04-16       Impact factor: 11.528

Review 7.  Aurora A kinase (AURKA) in normal and pathological cell division.

Authors:  Anna S Nikonova; Igor Astsaturov; Ilya G Serebriiskii; Roland L Dunbrack; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-08-03       Impact factor: 9.261

8.  Noncoding RNA Ginir functions as an oncogene by associating with centrosomal proteins.

Authors:  Suchismita Panda; Meenakshi Setia; Navjot Kaur; Varsha Shepal; Vivek Arora; Divya Kumari Singh; Abir Mondal; Abhishek Teli; Madhura Tathode; Rajendra Gajula; L C Padhy; Anjali Shiras
Journal:  PLoS Biol       Date:  2018-10-08       Impact factor: 8.029

9.  Spatio-temporal regulation of RAG2 following genotoxic stress.

Authors:  William Rodgers; Jennifer N Byrum; Hem Sapkota; Negar S Rahman; Robert C Cail; Shuying Zhao; David G Schatz; Karla K Rodgers
Journal:  DNA Repair (Amst)       Date:  2015-01-08

Review 10.  Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance.

Authors:  Mihaela Marina; Harold I Saavedra
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.